Please use this identifier to cite or link to this item: https://doi.org/10.1371/journal.pone.0173291
DC FieldValue
dc.titleDecline in changing montreal cognitive assessment (MoCA) scores is associated withpost-stroke cognitive decline determined by a formal neuropsychological evaluation
dc.contributor.authorTan H.H.
dc.contributor.authorXu J.
dc.contributor.authorTeoh H.L.
dc.contributor.authorChan B.P.-L.
dc.contributor.authorSeet R.C.S.
dc.contributor.authorVenketasubramanian N.
dc.contributor.authorSharma V.K.
dc.contributor.authorChen C.L.-H.
dc.contributor.authorDong Y.
dc.date.accessioned2019-11-01T07:54:40Z
dc.date.available2019-11-01T07:54:40Z
dc.date.issued2017
dc.identifier.citationTan H.H., Xu J., Teoh H.L., Chan B.P.-L., Seet R.C.S., Venketasubramanian N., Sharma V.K., Chen C.L.-H., Dong Y. (2017). Decline in changing montreal cognitive assessment (MoCA) scores is associated withpost-stroke cognitive decline determined by a formal neuropsychological evaluation. PLoS ONE 12 (3) : e0173291. ScholarBank@NUS Repository. https://doi.org/10.1371/journal.pone.0173291
dc.identifier.issn19326203
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/161202
dc.description.abstractObjectives We aimed to examine changes in the Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) scores within a one-year period after stroke/transient ischemic attack (TIA) in associating cognitive decline determined by a formal neuropsychological test battery. Methods Patients with ischemic stroke/TIA received MoCA and MMSE at baseline within 14 days after stroke/TIA, at 3 lusmn;6 months and 1-year follow-ups. The scores of MoCA and MMSE were considered to have declined if there were a reduction of -2 points in the respective scores measured across two time points. The decline in neuropsychological diagnosis transitional status was defined by a category transition from no cognitive impairment or any cognitive impairment to a more severe cognitive impairment or dementia. Results 275 patients with a mean age of 59.8 lusmn; 11.6 years, and education of 7.7 lusmn; 4.3 years completed all the assessments at baseline, 3 lusmn;6 months and 1-year follow-ups. A decline in MoCA scores from 3 lusmn;6 months to 1 year was associated with higher risk of decline in diagnosis transitional status (odd ratio = 3.21, p = 0.004) in the same time period whereas there was no association with a decline in MMSE scores. Conclusions The decline in MoCA scores from 3 lusmn;6 months to 1 year after stroke/TIA has three times higher risk for decline in the diagnosis transitional status. The decline of MoCA scores (reduction > 2points) is associated with the decline in neuropsychological diagnosis transitional status. © 2017 Tan et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceUnpaywall 20191101
dc.subjectadult
dc.subjectArticle
dc.subjectcerebrovascular accident
dc.subjectcognitive defect
dc.subjectdementia
dc.subjectdisease course
dc.subjectdisease severity
dc.subjectfemale
dc.subjectfollow up
dc.subjecthuman
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectmental deterioration
dc.subjectmiddle aged
dc.subjectMini Mental State Examination
dc.subjectMontreal cognitive assessment
dc.subjectneuropsychological test
dc.subjectpsychoeducation
dc.subjectscoring system
dc.subjecttransient ischemic attack
dc.subjectaged
dc.subjectCognitive Dysfunction
dc.subjectcomplication
dc.subjectdementia
dc.subjecteducational status
dc.subjectneuropsychological test
dc.subjectrisk factor
dc.subjectAdult
dc.subjectAged
dc.subjectCognitive Dysfunction
dc.subjectDementia
dc.subjectEducational Status
dc.subjectFemale
dc.subjectFollow-Up Studies
dc.subjectHumans
dc.subjectIschemic Attack, Transient
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectNeuropsychological Tests
dc.subjectRisk Factors
dc.subjectStroke
dc.typeArticle
dc.contributor.departmentDEPT OF MEDICINE
dc.contributor.departmentPHARMACOLOGY
dc.description.doi10.1371/journal.pone.0173291
dc.description.sourcetitlePLoS ONE
dc.description.volume12
dc.description.issue3
dc.description.pagee0173291
Appears in Collections:Elements
Staff Publications

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1371_journal_pone_0173291.pdf1.02 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons